title: Is second-line anti-tuberculosis drug susceptibility testing reliable?
authors.forename: S J
authors.initials: SJ
authors.lastname: Kim
authors.forename: M A
authors.initials: MA
authors.lastname: Espinal
authors.forename: C
authors.initials: C
authors.lastname: Abe
authors.forename: G H
authors.initials: GH
authors.lastname: Bai
authors.forename: F
authors.initials: F
authors.lastname: Boulahbal
authors.forename: L
authors.initials: L
authors.lastname: Fattorin
authors.forename: C
authors.initials: C
authors.lastname: Gilpin
authors.forename: S
authors.initials: S
authors.lastname: Hoffner
authors.forename: K M
authors.initials: KM
authors.lastname: Kam
authors.forename: N
authors.initials: N
authors.lastname: Martin-Casabona
authors.forename: L
authors.initials: L
authors.lastname: Rigouts
authors.forename: V
authors.initials: V
authors.lastname: Vincent
mesh_terms: D000995:Antitubercular Agents / Q000494:pharmacology*; D004352:Drug Resistance, Microbial; D018432:Drug Resistance, Multiple; D006306:Health Surveys; D006801:Humans; D008826:Microbial Sensitivity Tests / Q000592:standards*; D009169:Mycobacterium tuberculosis / Q000187:drug effects* / Q000472:pathogenicity*; D012016:Reference Values; D015203:Reproducibility of Results; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy; D014944:World Health Organization
chemical_list: D000995:Antitubercular Agents